Prestige floats $100 mil. note for Blacksmith buy
This article was originally published in The Tan Sheet
Prestige Brands sells $100 million worth of debt to help finance its acquisition of Blacksmith Brands. The senior notes the firm announced Oct. 22 will have the same terms as the 8.25 percent notes the company issued in March and are due in 2018. Prestige Sept. 20 announced its $190 million acquisition of year-old Blacksmith, which markets brands including denture products Efferdent and Effergrip, cough and cold products PediaCare and Luden's and allergy drug NasalCrom (1"The Tan Sheet" Sept. 27, 2010)
You may also be interested in...
On the eve of Blacksmith Brands' one-year anniversary, co-founder and CEO Peter Mann fulfills his promise to cash in on the startup in a $190 million sale to Prestige Brands Holdings, which Mann also helped launch
While endocrine-disrupting evidence was inconclusive, the Scientific Committee on Consumer Safety recommends more conservative limits on use of homosalate, octocrylene and benzophenone-3 in cosmetic products compared with current requirements under the European Cosmetics Product Regulation.
The risk of inadvertently growing SARS-CoV-2 virus in cell and gene therapies and possibly infecting patients and workers should be assessed and mitigated, the agency advises.